Anti-CEA (806.077)

Anti-CEA [806.077], Recombinant, IgG kappa, Rabbit
SKU
ABAAb03925-23.0-BT
Packaging Unit
1 mg
Manufacturer
Absolute Antibody

Availability: loading...
Price is loading...
CloneID: 806.077

Antigen Long Description: The original antibody was generated by immunizing BALB/C mice with CEA. The antibody was subsequently humanized.

Buffer Composition: PBS only.

Uniprot Accession No.: Q13984

Specificity Statement: The antibody is selective for CEA, exhibiting no cross reactivity to granulocytes.

Application Notes (Clone): The antibody-CPG2 conjugate showed anti-tumour activity in an ADEPT model. The antibody was employed to screen human normal and tumour tissues using sensitive three-stage indirect immunohistology on acetone-fixed, frozen cryostat sections. Further, the reactivity of the antibody was compared against A5B7. The two antibodies showed comparable results in the following tumours: colon tumours, NSCLC tumours, gastric tumours. The anti-tumour activity of the F(ab′)2-CPG2 conjugate antibody was evaluated in combination with the prodrug N(4-[N,N-bis(2-chloroethyl)amino]-phenoxycarbonyl)-L-glutamic acid in a human colorectal tumour xenograft model. The results demonstrated that the F(ab′)2-CPG2 conjugate antibody in combination with the PGP prodrug produced tumour regressions and prolonged growth delays which were statistically significant compared with control groups. The humanized version of the parental mouse antibody was also constructed (US6903203B2).
More Information
SKU ABAAb03925-23.0-BT
Manufacturer Absolute Antibody
Manufacturer SKU Ab03925-23.0-BT
Package Unit 1 mg
Quantity Unit STK
Reactivity Human, Mouse (Murine)
Clonality Recombinant
Application Immunohistochemistry, In Vivo Assay
Isotype IgG kappa
Host Rabbit
Product information (PDF) Download
MSDS (PDF) Download